MHRA CEO argues that for the UK’s long-term health and prosperity, regulation should help lead, rather than follow, innovation
UK MHRA · July 02, 2026
MHRA: Making regulation a catalyst, not a barrier, for UK life sciences
Original title: Making regulation a catalyst, not a barrier, for UK life sciences
MHRA CEO argues regulation should lead innovation rather than follow it for UK health and prosperity.
Published by UK MHRA. HealthSignal links to the original document; the summary above is extracted from the source text.